BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9498703)

  • 1. Role for C-MPL and its ligand thrombopoietin in early hematopoiesis.
    Katayama N; Itoh R; Kato T; Sugawara T; Mahmud N; Ohishi K; Masuya M; Aoki M; Minami N; Miyazaki H; Shiku H
    Leuk Lymphoma; 1997 Dec; 28(1-2):51-6. PubMed ID: 9498703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of the ligand for c-mpl, thrombopoietin, in early haemopoiesis.
    Itoh R; Katayama N; Kato T; Mahmud N; Masuya M; Ohishi K; Minami N; Miyazaki H; Shiku H
    Br J Haematol; 1996 Aug; 94(2):228-35. PubMed ID: 8759880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the thrombopoietin (TPO)/Mpl system: c-Mpl-like molecule/TPO signaling enhances early hematopoiesis in Xenopus laevis.
    Kakeda M; Kyuno J; Kato T; Nishikawa M; Asashima M
    Dev Growth Differ; 2002 Feb; 44(1):63-75. PubMed ID: 11869293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice.
    Ku H; Yonemura Y; Kaushansky K; Ogawa M
    Blood; 1996 Jun; 87(11):4544-51. PubMed ID: 8639822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of c-mpl in early hematopoiesis.
    Solar GP; Kerr WG; Zeigler FC; Hess D; Donahue C; de Sauvage FJ; Eaton DL
    Blood; 1998 Jul; 92(1):4-10. PubMed ID: 9639492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
    Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
    Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG; Quentmeier H
    Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand.
    Banu N; Wang JF; Deng B; Groopman JE; Avraham H
    Blood; 1995 Aug; 86(4):1331-8. PubMed ID: 7632939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin and its receptor.
    Wendling F; Vainchenker W
    Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential.
    Papayannopoulou T
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S69-73. PubMed ID: 8765421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin alone stimulates the early proliferation and survival of human erythroid, myeloid and multipotential progenitors in serum-free culture.
    Yoshida M; Tsuji K; Ebihara Y; Muraoka K; Tanaka R; Miyazaki H; Nakahata T
    Br J Haematol; 1997 Aug; 98(2):254-64. PubMed ID: 9266917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
    Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
    Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs.
    Xie X; Chan RJ; Johnson SA; Starr M; McCarthy J; Kapur R; Yoder MC
    Blood; 2003 Feb; 101(4):1329-35. PubMed ID: 12393382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
    Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
    Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-mpl, the thrombopoietin receptor.
    Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders.
    Li Y; Hetet G; Kiladjian JJ; Gardin C; Grandchamp B; Briere J
    Br J Haematol; 1996 Jan; 92(1):60-6. PubMed ID: 8562412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.